Accendra Health, Inc. (ACH) Stock Score, Valuation & Financial Research
Accendra Health, Inc. is in the Healthcare sector and Medical - Distribution industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 24/100.
Quick answer for ACH
Accendra Health, Inc. currently has a Wall Street Score of 24/100. The stored market price is $1.11. Its financial score is 11/100. Its valuation score is 0/100. The latest WSS change is +0.2 points. These figures are a research snapshot, not a buy or sell recommendation.
What Accendra Health, Inc. does
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home pat
ACH financial snapshot
- Wall Street Score:
- 24/100
- Current price:
- $1.11
- Market capitalization:
- $85.0M
- Revenue:
- $2.65B
- Net income:
- $-302.1M
- Free cash flow:
- $-303.1M
- Cash:
- $7.7M
- Total debt:
- $1.78B
- EPS:
- -3.91
- Financial score:
- 11/100
- Valuation score:
- 0/100
- Revenue score:
- 20/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-303.1M, showing cash burn in the current stored period.
- The balance sheet shows $7.7M of cash versus $1.78B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.2 points: ACH increased 0.2 points because Capital improved by 2 points.
- The current research record carries a corporate distress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 11/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research ACH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.